India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

A content creator named Kaajal recently shared on Instagram that she lost 5 kg in just four weeks after starting Mounjaro, calling the rapi...

Gurugram's law enforcement has taken a bold step by breaking up a ring creating counterfeit Mounjaro injections, with two individuals now i...

The Central Drugs Standard Control Organisation has moved about 95 officials across India. This reshuffle aims to improve compliance and le...

In India, appetite for weight-loss drugs is on the rise, with consumers increasingly turning to injectables such as Mounjaro and Ozempic fo...

Mounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...

With wedding season in full swing, Indian health clinics are rolling out specialized weight-loss packages that include popular drugs such a...

Novo Nordisk is slashing prices for its diabetes and weight loss drugs Ozempic and Wegovy in India. This move aims to make these treatments...

Eli Lilly remains optimistic about strong demand for its weight-loss and anti-diabetes injectable, tirzepatide (sold as Mounjaro), despite ...

Novo Nordisk has launched Ozempic in India at a competitive price, aiming to capture a significant share of the growing weight-loss market....

Eli Lilly's diabetes drug Mounjaro will be added to China's state health insurance from January 1, making it more accessible to the country...

Danish drugmaker Novo Nordisk is set to launch its popular diabetes drug Ozempic in India this month. This move aims to capture a significa...

A new pill, Orforglipron, is set to revolutionize weight loss and diabetes treatment. This daily pill, developed by Eli Lilly, has shown si...

Novo Nordisk will launch Ozempic in India. This injectable drug manages type 2 diabetes and aids weight loss. It enters a competitive marke...

Elon Musk revealed that he uses the weight-loss drug Mounjaro and praises it for having fewer side effects than Ozempic.

Novo Nordisk's launch of weight-loss and diabetes drugs Wegovy and Ozempic in India hinges on resolving supply issues. The company is scali...

According to doctors and fitness experts, queries come in every other day from (well-heeled) patients, asking whether they can take the exp...